Key result
The pooled prevalence of insulin-induced lipohypertrophy was 45.16% in children and adolescents and 41.3% in adults, driven by improper injection technique and longer diabetes duration.
Why the study?
What is the prevalence and what are the risk factors for insulin-induced lipohypertrophy in children and adolescents with type 1 diabetes mellitus?
What is the prevalence and what are the risk factors for insulin-induced lipohypertrophy in children and adolescents with type 1 diabetes mellitus?
Absolute Event Rate: 45.16% vs 41.3%
Improper insulin injection technique and longer duration of T1DM are key risk factors for lipohypertrophy, which is associated with poorer glycemic control and higher insulin requirements.
No takes yet. Share an insight, caveat, or question.
Soliman et al. (2022) conducted a review in Type 1 diabetes mellitus. Subcutaneous insulin injection was evaluated on Prevalence of lipohypertrophy. The pooled prevalence of insulin-induced lipohypertrophy was 45.16% in children and adolescents and 41.3% in adults, driven by improper injection technique and longer diabetes duration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: